Concepedia

Efgartigimod infusion in the treatment regimen for myasthenic crisis: A case report

Fang Sun, Ayush Batra, Daniel Dickson, Yuebing Li, En‐Ling Wu

Muscle & Nerve · 2024 · 10 citations · 3 references

DOI

Concepts

Abstract

The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.

References

3

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 800 citations

, , +6

Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial

James F. Howard, Vera Bril, Tuan Vu et al. · The Lancet Neurology · 2021 · 668 citations · Full text

, , +4

International consensus guidance for management of myasthenia gravis: Executive summary

Oxford University Research Archive (ORA) (University of Oxford) · 2016 · 88 citations · Full text

, , +13